Real‐World Treatment Effectiveness of Disease‐Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis

OBJECTIVE: The objective of this study was to compare the clinical effectiveness of biologic disease‐modifying antirheumatic drugs (bDMARDs) or Janus kinase inhibitors (JAKi) among seropositive versus seronegative patients with rheumatoid arthritis (RA) in a real‐world setting. METHODS: We used Optu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yinzhu, Liu, Jun, Desai, Rishi J., Kim, Seoyoung C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642251/
https://www.ncbi.nlm.nih.gov/pubmed/37775970
http://dx.doi.org/10.1002/acr2.11548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642251/
https://www.ncbi.nlm.nih.gov/pubmed/37775970
http://dx.doi.org/10.1002/acr2.11548

Ejemplares similares